Revenues increased 15% YoY to | 1685 crore (I-direct estimate: | 1712 crore) on the back of 11% increase in healthcare business to | 920 crore (I-direct estimate: | 939 crore) and 21% increase in pharmacy business to | 764 crore (I-direct estimate: | 773 crore) EBITDA margins declined 252 bps YoY to 10.3% (I-direct estimate: 10.6%) mainly due to an adverse segment mix. EBITDA declined 8% YoY to | 174 crore (I-direct estimate: | 181 crore) Adjusted net profit declined 51% to | 35 crore (I-direct estimate: | 54...